Jigar Choksey - Jun 9, 2022 Form 4/A - Amendment Insider Report for Ventyx Biosciences, Inc. (VTYX)

Role
Director
Signature
/s/ Christopher Krueger, as Attorney-in-Fact
Stock symbol
VTYX
Transactions as of
Jun 9, 2022
Transactions value $
$0
Form type
4/A - Amendment
Date filed
7/1/2022, 04:23 PM
Date Of Original Report
Jun 10, 2022
Previous filing
Oct 20, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding VTYX Stock Option (right to buy) 0 Jun 9, 2022 Common Stock 0 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Form 4 filed on June 10, 2022, erroneously reported that Mr. Choksey received an annual option award under the Company's Outside Director Compensation Policy on June 9, 2022. However, Mr. Choksey had previously waived his right to receive such award and such award did not occur.